North America Automated Cell Cultures Market is expected to grow with a CAGR of 9.0% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below:
The North America automated cell cultures market is a highly fragmented market, which includes many key players. The market has witnessed increased strategic developments owing to favourable market scenarios.
The major players dealing in the North America automated cell cultures market are introducing a strong range of products providers, launching new products, and adopting strategic initiatives such as acquisition, agreement, business expansion, award, and recognition. This helped companies to maximize sales with an enhanced product portfolio.
Lonza is the dominating player in the North America automated cell cultures market. The other key players existing in the market are Sartorius AG, Danaher, Nexcelom Bioscience LLC., HiMedia Laboratories, Cell Culture Company, LLC, Advanced Instruments, NanoEntek America, Inc., FUJIFILM Holdings America Corporation, Hitachi, Ltd., Kawasaki Heavy Industries, Ltd., Thrive Bioscience, Inc., Eppendorf AG, CellGenix GmbH, Scientica Instrumentation, Inc., ChemoMetec, PromoCell GmbH, Thermo Fisher Scientific Inc., BioSpherix, Ltd., Merck KGaA, Tecan Trading AG, Hamilton Company, BD, Benchmark Scientific, Inc., RWD Life Science Co., LTD, Cytiva (A subsidiary of Danaher Corporation), Corning Incorporated, Bulldog-Bio and among others.
Lonza has headquarters in Basel, Switzerland, and was founded in 1897. It has public ownership. The company focuses on enabling treatments that prevent illness and supports healthier lifestyles, optimizes scientific innovation and manufacturing technology to enable its customers to serve their patients and consumers.
The company operates its business through two business segments, Lonza Pharma Biotech
& Nutrition, Lonza Speciality Ingredients. Under which Lonza Speciality Ingredients is the market-focused segment. The company has wide product categories such as primary and stem cells, Cell Bio Services, Bioprocessing Media, Culture Media & Reagents, 3D Culture Products, ADME & Toxicology, Transfection, Cell Analysis, Electrophoresis, and Endotoxin Detection. Under which Culture Media & Reagents is the market-focused category. The company is attaining lucrative growth through several strategic initiatives.
The company has a wide presence across Europe, North and Central America, Latin America, Asia, Africa.
The company also has various subsidiary companies such as Lonza KK (Japan), Lonza NZ Limited (New Zealand), Lonza India Private Limited (India), Lonza Bioscience Singapore Pte Ltd (Singapore), Lonza Consumer Health Inc. (United States), among others.
THERMOFISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. was found in 1960. The companies headquarter is in Massachusetts, U.S. It has public ownership. The company is focused on manufacturing scientific instruments, consumables, and chemicals. The company operates in four business segments such as Life Science Solutions, Analytical Instruments, Specialty Diagnostics, Laboratory Products & Services. Under which Laboratory Products & Services is the market-focused segment. The company has various product categories such as Lifesciences, Industrial & Applied Sciences, Clinical & Diagnostics, Lab Solutions, Digital Solutions, Brands. Under which Lifesciences is the market-focused category. The company is attaining lucrative growth through several strategic initiatives.
The company has a wide presence in the Americas, Europe, Asia-Pacific, Middle East, and Africa. The company also has various subsidiary companies such as Patheon (U.S.), Dionex (U.S.), Cole Palmer (U.S.), Affymertrix (U.S.), Applied Biosystems (U.S.), Thermo Trace Limited (Australia), Laboratory Management Systems Inc. (Delaware), Jouan Nordics AS (Denmark), among others.
BD has headquarters in New Jersey, U.S., founded in 1897. It has public ownership. The company is engaged in developing, manufacturing, and selling a broad range of medical supplies, devices, laboratory equipment, and diagnostic products used by healthcare institutions also provides customer solutions that are focused on improving medication management and patient safety. The company has various business segments such as BD Medical, BD Life Science, BD Interventional. Under which BD Life Science is the market-focused segment.
The company has various product categories that are Anesthesia Delivery, Biopsy, Biosciences, Bio surgery, Cervical Cancer Screening, Diabetes Care, Drainage, Drug Delivery System, Gastrointestinal Care, Hazardous Drug Safety, Hernia Repair, and Fixation, Homecare, Infection Prevention, Infusion Therapy, Interventional Specialties, Lab Automation, Medication and Supply Management, Microbiology Solution, Molecular Diagnostic, Patient Monitoring, Prostrate Health, Respiratory Care, Sharp Disposal Solution, Software Solution, Specimen Collection, Surgical Instruments, Syringes and Needles, Urology and Kidney Health, Vascular Access, Vascular Surgery, and Wound Care. Under which Microbiology Solution is the market-focused category.
The company is attaining lucrative growth through several strategic initiatives.
The company has a presence in Americas, Europe, Asia-Pacific, Middle East, and Africa. The company also has various subsidiary companies such as Care Fusion (U.S.), C. R. Bard (U.S.), Accuri Cytometers Inc. (U.S.), Becton Dickson UK ltd. (U.K.), Straub medical AG (Switzerland), among others.
Global Automated Cell Cultures Market - Industry Trends and Forecast to 2029
Asia-Pacific Automated Cell Cultures Market – Industry Trends and Forecast to 2028
Europe Automated Cell Cultures Market – Industry Trends and Forecast to 2028
North America Automated Cell Cultures Market – Industry Trends and Forecast to 2028
Middle East and Africa Automated Cell Cultures Market – Industry Trends and Forecast to 2028